Annotation Detail

Information
Associated Genes
BRCA1
Associated Variants
BRCA1 LOSS-OF-FUNCTION
BRCA1 LOSS-OF-FUNCTION
Associated Disease
prostate cancer
Source Database
CIViC Evidence
Description
In a study of 2,019 patients with prostate cancer, 18 had germline BRCA1 mutations, 61 had germline BRCA2 mutations and 1,940 were non-carriers. Patients with BRCA1/2 mutations had a 2-fold higher incidence of poorly differentiated cancer (Gleason score >8), a higher incidence of advanced stage (37% vs. 28%; P=0.003), a higher incidence of nodal involvement (15% vs. 5%; P=0.0005), and a higher incidence of metastatic spread (18% vs. 9%; P=0.005).
Variant Origin
germline
Variant Origin
Rare Germline
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/1523
Gene URL
https://civic.genome.wustl.edu/links/genes/6
Variant URL
https://civic.genome.wustl.edu/links/variants/131
Rating
3
Evidence Type
Prognostic
Disease
Prostate Cancer
Evidence Direction
Supports
Evidence Level
B
Clinical Significance
Poor Outcome
Pubmed
23569316
Drugs